Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
60
FDA:58
CANADA:1
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk
Phase 4
Recruiting
- Conditions
- Lactating Mother
- Interventions
- Drug: Vyleesi (Bremelanotide Injection)
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-07-14
- Lead Sponsor
- Cosette Pharmaceuticals, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06867835
- Locations
- 🇺🇸
First Excellence Research Group LLC, Doral, Florida, United States
News
No news found